You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

PENICILLAMINE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for penicillamine and what is the scope of patent protection?

Penicillamine is the generic ingredient in three branded drugs marketed by Valeant Pharms Intl, Ani Pharms, Apotex, Breckenridge, Dr Reddys, Granules, Invagen Pharms, Navinta Llc, Par Pharm Inc, Watson Labs Inc, Mylan Speciality Lp, Lupin Ltd, and Teva Pharms Usa, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for penicillamine. Fourteen suppliers are listed for this compound.

Drug Prices for PENICILLAMINE

See drug prices for PENICILLAMINE

Recent Clinical Trials for PENICILLAMINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Alexion PharmaceuticalsPhase 2
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEarly Phase 1
GMP-Orphan SASPhase 3

See all PENICILLAMINE clinical trials

Pharmacology for PENICILLAMINE
Medical Subject Heading (MeSH) Categories for PENICILLAMINE

US Patents and Regulatory Information for PENICILLAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd PENICILLAMINE penicillamine TABLET;ORAL 212933-001 Nov 30, 2020 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Breckenridge PENICILLAMINE penicillamine CAPSULE;ORAL 215409-001 Aug 23, 2021 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apotex PENICILLAMINE penicillamine CAPSULE;ORAL 213310-001 Apr 28, 2020 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Par Pharm Inc PENICILLAMINE penicillamine CAPSULE;ORAL 211231-001 Dec 23, 2019 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.